Biopolymer marker indicative of disease state having a...

Details Biopolymer marker indicative of disease state having a... Biopolymer marker indicative of disease state having a...

2006-08-08

2006-08-08

Zeman, Mary K. (Department: 1631)

Chemistry: analytical and immunological testing

Nuclear magnetic resonance, electron spin resonance or other...

C436S811000, C702S019000, C702S020000, C530S300000, C530S324000, C530S325000

Reexamination Certificate

active

07087435

ABSTRACT:
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer.

REFERENCES:
patent: 4687808 (1987-08-01), Jarrett et al.
patent: 4837170 (1989-06-01), Ohe et al.
patent: 5062935 (1991-11-01), Schlag et al.
patent: 5532136 (1996-07-01), Carlson et al.
patent: 5766883 (1998-06-01), Ballance et al.
patent: 6020208 (2000-02-01), Hutchens et al.
patent: 6620786 (2003-09-01), Jackowski et al.
patent: WO 90/14148 (1990-11-01), None
patent: WO 93/24834 (1993-12-01), None
patent: WO 98/07036 (1998-02-01), None
Laussac, J-P. et al. International Journal of Peptide Protein Research (1985) vol. 26, No. 4 pp. 425-438.
Roehr, U. et al. Liebigs Annalen der Chemie (1988) vol. 9 pp. 881-884, Abstract Only.
Richter et al, Composition of the peptide fraction in human blood plasma: database of circulating human peptides, J. Chrom. B. Biomed. Sci. Appl. 726, 1-2, (1999), pp. 25-35.
Takahashi et al, Rapid and sensitive immunoassay for the measurement of serum S100B using isoform-specific monoclonal antibody, Clin. Chem., 45, 8, (1999), pp. 1307-1311.
Feskens, et al., “Hyperinsulinemia, Risk Factors, and Coronary Heart Disease”, Arteriosclerosis and Thrombosis, (1994) vol. 14, No. 10, pp. 1641-1647.

Affiliated with

Also associated with

Rating

Biopolymer marker indicative of disease state having a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biopolymer marker indicative of disease state having a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biopolymer marker indicative of disease state having a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3674356